Trials / Completed
CompletedNCT04335266
A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects
A Randomized, Open, Single-center, Two-cycle, Double-sequence Crossover Study to Investigate the Effects of a High-fat Diet on the Pharmacokinetics of Healthy Chinese Male Adult Subjects After Oral Administration of SHR2554 Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the effect of high-fat diet on pharmacokinetics of healthy Chinese male adult subjects after oral administration of SHR2554 tablets. The secondary objective of the study is to evaluate the safety of single dose of SHR2554 orally in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2554 | SHR2554 |
Timeline
- Start date
- 2019-08-06
- Primary completion
- 2019-09-09
- Completion
- 2020-03-30
- First posted
- 2020-04-06
- Last updated
- 2020-04-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04335266. Inclusion in this directory is not an endorsement.